“秉持严谨、深入、持续、开放与创新的态度,尊重他人成果,携手交流共进,推动科研发展。”
Research Frontline
科研前线
01
—
问题论文
标题:Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis
期刊:Signal Transduction and Targeted Therapy
单位:中国医学科学院北京协和医学院
发表时间:2022年10月24日
DOI: 10.1038/s41392-022-01199-1
研究摘要:
Whereas it is appreciated that cancer cells rewire lipid metabolism to survive and propagate, the roles of lipid metabolism in metastasis remain largely unknown. In this study, using esophageal squamous cell carcinoma (ESCC) as a pulmonary metastasis model, we find that the enzyme fatty acid 2-hydroxylase (FA2H), which catalyzes the hydroxylation of free fatty acids (FAs), is enriched in a subpopulation of ESCC cells with high metastatic potential, and that FA2H knockdown markedly mitigates metastatic lesions. Moreover, increased FA2H expression is positively associated with poor survival in patients with ESCC. Lipidomics analysis identifies that two dihydroceramides-Cer(d18:0/24:0) and Cer(d18:0/24:1)-are increased in FA2H-depleted metastasizing ESCC cells. Upon administration, Cer(d18:0/24:0) and Cer(d18:0/24:1) impair the formation of overt metastases in a mouse experimental metastasis model. Then, forkhead box protein C2 (FOXC2) and FA2H are found to be co-upregulated in metastatic ESCC cell populations and ESCC specimens, and FA2H expression is further experimentally verified to be transcriptionally induced by FOXC2, which is boosted per se by tumour necrosis factor α (TNFα), a critical pro-metastasis cytokine in the tumour microenvironment, in metastasizing cells. Together, these results demonstrate that TNFα-FOXC2-FA2H is a novel signaling axis to promote metastasis, and its downstream dihydroceramide products could be promising drugs to intervene in metastasis.02
—
具体说明
参考信息
https://pubmed.ncbi.nlm.nih.gov/36274060/
https://pubpeer.com/publications/84C82AD45DAC7F72CE7CC9E8DAE0D9#
本平台对于科研问题的探讨,始终保持严谨、深入、持续、开放和创新的态度。
所有推文信源,均来源于pubpeer、For Better Science等网站公开质疑。
我们从来没有、也永远不会主动查重论文并去pubpeer上质疑。
我们尊重他人的研究成果和贡献,通过交流和合作,共同推动科研领域的进步和
发展。